LOFIEGO, MARIA FORTUNATA
 Distribuzione geografica
Continente #
EU - Europa 333
NA - Nord America 268
AS - Asia 37
Totale 638
Nazione #
US - Stati Uniti d'America 268
IT - Italia 120
IE - Irlanda 87
GB - Regno Unito 32
SE - Svezia 24
CN - Cina 14
RU - Federazione Russa 14
UA - Ucraina 14
DE - Germania 11
SG - Singapore 11
FI - Finlandia 9
FR - Francia 9
VN - Vietnam 8
ES - Italia 7
AE - Emirati Arabi Uniti 2
BE - Belgio 2
GR - Grecia 1
LA - Repubblica Popolare Democratica del Laos 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
UZ - Uzbekistan 1
Totale 638
Città #
Dublin 87
Fairfield 51
Ashburn 29
Southend 29
Woodbridge 25
Seattle 20
Wilmington 18
Houston 14
Jacksonville 13
Rome 13
New York 12
Cambridge 11
Siena 11
Chandler 9
Dong Ket 8
Helsinki 8
Princeton 8
Florence 7
Málaga 7
Shanghai 6
Altamura 5
San Giovanni Valdarno 5
San Mateo 5
Singapore 5
Cagliari 4
Labico 4
Milan 4
Palermo 4
Arienzo 3
Ascoli Piceno 3
Dearborn 3
Empoli 3
Fremont 3
Redwood City 3
San Diego 3
Abu Dhabi 2
Ann Arbor 2
Beijing 2
Brussels 2
Catania 2
Chiusdino 2
Cortona 2
Gavirate 2
Montevarchi 2
Moscow 2
Salerno 2
Sesto Fiorentino 2
Asciano 1
Athens 1
Boardman 1
Cascina 1
Changsha 1
Ferentino 1
Figline Valdarno 1
Genoa 1
Guiyang 1
Kilburn 1
Lambeth 1
Lappeenranta 1
Lincoln 1
Monteriggioni 1
Nanchang 1
Nanjing 1
North Salt Lake 1
Oslo 1
Pistoia 1
Reggio Calabria 1
Roseto Degli Abruzzi 1
San Francisco 1
Scarperia 1
Sollentuna 1
Stockholm 1
Tashkent 1
Torino 1
Trieste 1
Vientiane 1
Warsaw 1
Washington 1
Totale 498
Nome #
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13–15, 2016 138
Circulating levels of PD-L1 in mesothelioma patients from the NIBIT-MESO-1 study: Correlation with survival 121
Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5–7, 2017 113
A NEW HUMAN CELL-BASED VACCINE FOR CANCER THERAPY: PRE-CLINICAL CHARACTERIZATION 94
null 56
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines 46
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 37
Immunotherapy of brain metastases: breaking a "dogma" 35
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial 26
Totale 666
Categoria #
all - tutte 2.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020145 0 0 1 3 28 15 18 21 23 16 11 9
2020/2021123 6 14 6 6 12 13 10 19 7 11 4 15
2021/202278 2 16 7 3 5 8 2 2 4 6 13 10
2022/2023103 6 4 13 4 11 23 8 5 11 10 5 3
2023/2024177 6 4 15 7 4 42 49 18 10 6 10 6
2024/202525 13 12 0 0 0 0 0 0 0 0 0 0
Totale 666